Dextech Medical (Germany) Top Insiders

Dextech Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.1256) % which means that it has lost $0.1256 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1864) %, meaning that it generated substantial loss on money invested by shareholders. Dextech Medical's management efficiency ratios could be used to measure how well Dextech Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Dextech Medical's Total Assets are most likely to decrease significantly in the upcoming years. The Dextech Medical's current Total Current Assets is estimated to increase to about 19.3 M, while Non Current Assets Total are projected to decrease to roughly 9.2 M. The current Common Stock Shares Outstanding is estimated to decrease to about 14.8 MDextech Medical holds a total of 18.49 Million outstanding shares. Dextech Medical AB shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.35 percent of Dextech Medical AB outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Dextech Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Dextech Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Dextech Medical Workforce Comparison

The company has Profit Margin (PM) of (1.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Dextech Medical AB Benchmark Summation

Dextech Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Dextech Medical AB often depends on how effective the management is. Dextech Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Dextech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Dextech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Dextech Medical's price analysis, check to measure Dextech Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dextech Medical is operating at the current time. Most of Dextech Medical's value examination focuses on studying past and present price action to predict the probability of Dextech Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dextech Medical's price. Additionally, you may evaluate how the addition of Dextech Medical to your portfolios can decrease your overall portfolio volatility.